Fresenius Kabi, and TQ Therapeutics, announced that they have entered into a strategic-development agreement under which Fresenius Kabi has an exclusive license to develop, manufacture, and distribute ...
NASA has quietly hit pause on what it billed as its first dedicated hunt for alien biosignatures, reacting to fresh data that raised more questions than answers about how to tell life’s fingerprints ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results